Travere Therapeutics, the IgA Nephropathy Foundation, and NephCure Kidney International Partner to Launch RKD & Me, a Campaign to Raise Awareness of Rare Kidney Disease

Developed in collaboration with the rare kidney disease community, RKD & Me aims to amplify the experiences of people living with rare kidney disease. SAN DIEGO , Nov. 15, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. , the IgA Nephropathy Foundation , and NephCure Kidney International today

View Full Press Release